These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20878207)

  • 1. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis.
    Grover PK; Hardingham JE; Cummins AG
    Cancer Metastasis Rev; 2010 Dec; 29(4):761-75. PubMed ID: 20878207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycoprotein hGC-1 binds to cadherin and lectins.
    Liu W; Chen L; Zhu J; Rodgers GP
    Exp Cell Res; 2006 Jun; 312(10):1785-97. PubMed ID: 16566923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.
    van der Flier LG; Haegebarth A; Stange DE; van de Wetering M; Clevers H
    Gastroenterology; 2009 Jul; 137(1):15-7. PubMed ID: 19450592
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of cells expressing OLFM4 and LGR5 mRNA by in situ hybridization in the yolk sac and small intestine of embryonic and early post-hatch chicks.
    Zhang H; Wong EA
    Poult Sci; 2018 Feb; 97(2):628-633. PubMed ID: 29155957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells.
    Kobayashi D; Koshida S; Moriai R; Tsuji N; Watanabe N
    Cancer Sci; 2007 Mar; 98(3):334-40. PubMed ID: 17270022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
    Yu L; Wang L; Chen S
    Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor.
    Chin KL; Aerbajinai W; Zhu J; Drew L; Chen L; Liu W; Rodgers GP
    Br J Haematol; 2008 Nov; 143(3):421-32. PubMed ID: 18764868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
    Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
    Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.
    Li H; Rodriguez-Canales J; Liu W; Zhu J; Hanson JC; Pack S; Zhuang Z; Emmert-Buck MR; Rodgers GP
    Am J Pathol; 2013 Oct; 183(4):1329-38. PubMed ID: 24070418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.
    Guette C; Valo I; Vétillard A; Coqueret O
    Proteomics Clin Appl; 2015 Feb; 9(1-2):58-63. PubMed ID: 25400027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes.
    Tanaka K; Okamoto S; Ishikawa Y; Tamura H; Hara T
    Oncogene; 2009 May; 28(21):2142-51. PubMed ID: 19398953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC.
    Li H; Chaitankar V; Zhu J; Chin K; Liu W; Pirooznia M; Rodgers GP
    Sci Rep; 2020 Dec; 10(1):21924. PubMed ID: 33318499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactomedin 4 defines a subset of human neutrophils.
    Clemmensen SN; Bohr CT; Rørvig S; Glenthøj A; Mora-Jensen H; Cramer EP; Jacobsen LC; Larsen MT; Cowland JB; Tanassi JT; Heegaard NH; Wren JD; Silahtaroglu AN; Borregaard N
    J Leukoc Biol; 2012 Mar; 91(3):495-500. PubMed ID: 22187488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
    Ohkuma R; Yada E; Ishikawa S; Komura D; Ishizaki H; Tamada K; Kubota Y; Hamada K; Ishida H; Hirasawa Y; Ariizumi H; Satoh E; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Yokobori T; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Izumizaki M; Kobayashi S; Tsunoda T; Wada S
    PLoS One; 2020; 15(1):e0226707. PubMed ID: 31923206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue repair and stem cell renewal in carcinogenesis.
    Beachy PA; Karhadkar SS; Berman DM
    Nature; 2004 Nov; 432(7015):324-31. PubMed ID: 15549094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immortal DNA strand cosegregation requires p53/IMPDH-dependent asymmetric self-renewal associated with adult stem cells.
    Rambhatla L; Ram-Mohan S; Cheng JJ; Sherley JL
    Cancer Res; 2005 Apr; 65(8):3155-61. PubMed ID: 15833845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation.
    Waterman EA; Sakai N; Nguyen NT; Horst BA; Veitch DP; Dey CN; Ortiz-Urda S; Khavari PA; Marinkovich MP
    Cancer Res; 2007 May; 67(9):4264-70. PubMed ID: 17483338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular permutation of granulocyte colony-stimulating factor.
    Feng Y; Minnerly JC; Zurfluh LL; Joy WD; Hood WF; Abegg AL; Grabbe ES; Shieh JJ; Thurman TL; McKearn JP; McWherter CA
    Biochemistry; 1999 Apr; 38(14):4553-63. PubMed ID: 10194377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.